Ionis Pharmaceuticals, Inc.
Conjugated Antisense Compounds for Use in Therapy
Last updated:
Abstract:
Provided herein are methods of administering gapmer oligomeric compounds with GalNAc conjugate groups to a human.
Status:
Application
Type:
Utility
Filling date:
28 Jul 2020
Issue date:
10 Jun 2021